Is DNSP-11 FDA approved?
No. This profile records DNSP-11 as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Longevity CATEGORY
DNSP-11
THE DOPAMINE PROTECTOR
Dopamine Neuron Stimulating Peptide-11
DNSP-11 is derived from a protein called GDNF (glial cell line-derived neurotrophic factor) that protects dopamine-producing neurons. It helps these neurons survive, grow, and function better. That makes it promising for Parkinson's disease and age-related dopamine decline. Unlike full GDNF, this small peptide can be delivered nasally.
DNSP-11
DNSP-11
DNSP-11
DNSP-11 Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About DNSP-11
What dose does The Peptide App Clinical Team recommend for DNSP-11?
Dose: 200 mcg daily (intranasal).
MORE CONTEXT ›
Schedule: daily. Cycle: 3 weeks on, then assess. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this DNSP-11 guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
ERK Activation
Activates growth signaling pathways in dopamine neurons
Dopamine Modulation
Improves dopamine turnover without increasing baseline levels
Neuroprotection
Protects neurons from oxidative stress and mitochondrial damage
People with Parkinson's or at risk for it
Those with dopamine-related conditions
Aging individuals concerned about brain health
Anyone wanting to protect dopamine neurons
Researchers studying neurodegeneration
DNSP-11 Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES